NCT07109414 2026-03-09Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)Novita Pharmaceuticals, Inc.Phase 2/3 Active not recruiting380 enrolled